Abstract
We reviewed the records of 33 patients with leukemia who experienced influenza during the period from October 2000 to March 2004. Three (38%) of the 8 patients who did not receive neuraminidase inhibitor therapy and none of the 25 patients who received it died of influenza pneumonia (P = .001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia.
Original language | English (US) |
---|---|
Pages (from-to) | 964-967 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 44 |
Issue number | 7 |
DOIs | |
State | Published - Apr 1 2007 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases